Gw Pharmaceuticals Plc Stock Short Ratio
GW Pharmaceuticals Plc fundamentals help investors to digest information that contributes to GW Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of GWPH Stock. The fundamental analysis module provides a way to measure GW Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GW Pharmaceuticals stock.
GWPH |
GW Pharmaceuticals Plc Company Short Ratio Analysis
GW Pharmaceuticals' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current GW Pharmaceuticals Short Ratio | 1.15 X |
Most of GW Pharmaceuticals' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GW Pharmaceuticals Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, GW Pharmaceuticals Plc has a Short Ratio of 1.15 times. This is 70.51% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The short ratio for all United States stocks is 71.25% higher than that of the company.
GWPH Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GW Pharmaceuticals' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GW Pharmaceuticals could also be used in its relative valuation, which is a method of valuing GW Pharmaceuticals by comparing valuation metrics of similar companies.GW Pharmaceuticals is currently under evaluation in short ratio category among related companies.
GWPH Fundamentals
Return On Equity | -7.92 | |||
Return On Asset | -3.55 | |||
Profit Margin | (11.03) % | |||
Operating Margin | (9.82) % | |||
Current Valuation | 6.42 B | |||
Shares Outstanding | 31.54 M | |||
Shares Owned By Insiders | 0.20 % | |||
Shares Owned By Institutions | 80.35 % | |||
Number Of Shares Shorted | 693.73 K | |||
Price To Earning | 126.70 X | |||
Price To Book | 9.24 X | |||
Price To Sales | 12.92 X | |||
Revenue | 527.2 M | |||
Gross Profit | 489.67 M | |||
EBITDA | (39.01 M) | |||
Net Income | (58.13 M) | |||
Cash And Equivalents | 486.75 M | |||
Cash Per Share | 15.53 X | |||
Total Debt | 43.64 M | |||
Debt To Equity | 0.06 % | |||
Current Ratio | 4.57 X | |||
Book Value Per Share | 23.70 X | |||
Cash Flow From Operations | (27.39 M) | |||
Short Ratio | 1.15 X | |||
Earnings Per Share | (1.86) X | |||
Price To Earnings To Growth | 3.61 X | |||
Number Of Employees | 1.16 K | |||
Beta | 1.67 | |||
Market Capitalization | 6.81 B | |||
Total Asset | 453.18 M | |||
Retained Earnings | (813.7 M) | |||
Working Capital | 369.57 M | |||
Current Asset | 404.52 M | |||
Current Liabilities | 34.95 M | |||
Z Score | 93.2 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in GWPH Stock
If you are still planning to invest in GW Pharmaceuticals Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GW Pharmaceuticals' history and understand the potential risks before investing.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stocks Directory Find actively traded stocks across global markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Commodity Directory Find actively traded commodities issued by global exchanges |